Clinical Trials Browser

Phase 2 × peficitinib × Lymphoid × Clear all

NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Phase 2 Completed

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity